50 results
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... who are higher risk ... AcutePE #Management #CriticalCare
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... - Risk Stratification ... @nickmmark #Pulmonary ... #Embolism #Risk ... stratification #criticalcare
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
Infection Control Risk ... Respiratory Cardiac Hematologic ... #COVID19 #ICU #criticalcare
Suggested algorithm for follow-up of monoclonal gammopathy of undetermined significance (MGUS)
Mayo Clinic Risk Stratification Model. CBC,
Suggested algorithm ... ) Mayo Clinic Risk ... MGUS #Followup #algorithm ... diagnosis #management #hematology
#Diagnosis #EM #IM #PERC #Low #Risk #Pulmonary #Embolism #PulmonaryEmbolism #Algorithm #RebelEM
IM #PERC #Low #Risk ... #Pulmonary #Embolism ... PulmonaryEmbolism #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... thrombosis; PE = pulmonary ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management #Hematology
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
and Management Algorithm ... to arm/jaw, CAD risk ... Limb ischemia Pulmonary ... CP, Dyspnea, PE risk ... Diagnosis #Management #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... patients at high risk ... interactions and bleeding risk ... also balance the risk ... Anticoagulation #Management #Hematology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... fatigue; Increases risk ... #Indications #Pharmacology ... #hematology
Rheumatoid Arthritis Summary
MCP and PIP Involvement, Spares DIP, Carpal Tunnel, Sicca Syndrome, Epi/Scleritis, Heart Disease, Rheumatoid
Rheumatoid Nodules, Pulmonary ... splenomegaly), Increased Risk ... RA #diagnosis #rheumatology